L N Voruganti

Summary

Affiliation: University of Western Ontario
Country: Canada

Publications

  1. ncbi request reprint Cannabis induced dopamine release: an in-vivo SPECT study
    L N Voruganti
    Institute of Medical Science, University of Toronto, Toronto, ON, Canada
    Psychiatry Res 107:173-7. 2001
  2. ncbi request reprint Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging
    L Voruganti
    Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
    Neuropsychopharmacology 25:642-50. 2001
  3. ncbi request reprint Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia
    Lakshmi N P Voruganti
    Institute of Medical Science, University of Toronto, Toronto, Canada
    Schizophr Res 56:37-46. 2002
  4. ncbi request reprint Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study
    L Voruganti
    Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
    Schizophr Res 57:201-8. 2002
  5. ncbi request reprint Intervention research in psychosis: issues related to the assessment of quality of life
    A G Awad
    Mental Health Program, Humber River Regional Hospital, Toronto, Ontario, Canada
    Schizophr Bull 26:557-64. 2000
  6. ncbi request reprint Impact of atypical antipsychotics on quality of life in patients with schizophrenia
    A George Awad
    Institute of Medical Science and Department of Psychiatry, University of Toronto, Humber River Regional Hospital, Toronto, Ontario, Canada
    CNS Drugs 18:877-93. 2004
  7. ncbi request reprint New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?
    A George Awad
    University of Toronto, Institute of Medical Science, Ontario
    Can J Psychiatry 49:297-302. 2004
  8. ncbi request reprint Body weight, image and self-esteem evaluation questionnaire: development and validation of a new scale
    A George Awad
    Department of Psychiatry, Humber Regional Hospital, 1575 Keele Street, Toronto M6M 3Z4, Canada
    Schizophr Res 70:63-7. 2004
  9. pmc What's in a name? The evolution of the nomenclature of antipsychotic drugs
    Caroline King
    Department of Psychiatry, University of Western Ontario, London, Ont
    J Psychiatry Neurosci 27:168-75. 2002
  10. ncbi request reprint Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT study
    Lakshmi N P Voruganti
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, and Humber River Regional Hospital, Toronto, Ontario, Canada
    Schizophr Res 88:179-86. 2006

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Cannabis induced dopamine release: an in-vivo SPECT study
    L N Voruganti
    Institute of Medical Science, University of Toronto, Toronto, ON, Canada
    Psychiatry Res 107:173-7. 2001
    ....
  2. ncbi request reprint Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging
    L Voruganti
    Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
    Neuropsychopharmacology 25:642-50. 2001
    ....
  3. ncbi request reprint Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia
    Lakshmi N P Voruganti
    Institute of Medical Science, University of Toronto, Toronto, Canada
    Schizophr Res 56:37-46. 2002
    ....
  4. ncbi request reprint Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study
    L Voruganti
    Department of Psychiatry, University of Western Ontario, London, Ontario, Canada
    Schizophr Res 57:201-8. 2002
    ..We examined the long-term consequences of switching patients from conventional to novel antipsychotic drugs, from a patient's perspective...
  5. ncbi request reprint Intervention research in psychosis: issues related to the assessment of quality of life
    A G Awad
    Mental Health Program, Humber River Regional Hospital, Toronto, Ontario, Canada
    Schizophr Bull 26:557-64. 2000
    ..Unless these issues are adequately clarified and resolved, the recent heightened interest in the concept of quality of life may fade away, and that would be a missed opportunity in the mental health field...
  6. ncbi request reprint Impact of atypical antipsychotics on quality of life in patients with schizophrenia
    A George Awad
    Institute of Medical Science and Department of Psychiatry, University of Toronto, Humber River Regional Hospital, Toronto, Ontario, Canada
    CNS Drugs 18:877-93. 2004
    ....
  7. ncbi request reprint New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?
    A George Awad
    University of Toronto, Institute of Medical Science, Ontario
    Can J Psychiatry 49:297-302. 2004
    ..This overview reviews the impact of second-generation antipsychotics on less frequently researched outcomes such as medication-adherence behaviour, quality of life, and subjective tolerability in patients with schizophrenia...
  8. ncbi request reprint Body weight, image and self-esteem evaluation questionnaire: development and validation of a new scale
    A George Awad
    Department of Psychiatry, Humber Regional Hospital, 1575 Keele Street, Toronto M6M 3Z4, Canada
    Schizophr Res 70:63-7. 2004
    ....
  9. pmc What's in a name? The evolution of the nomenclature of antipsychotic drugs
    Caroline King
    Department of Psychiatry, University of Western Ontario, London, Ont
    J Psychiatry Neurosci 27:168-75. 2002
    ..This article examines the origins, progenitors and usage of the word "antipsychotic" and explores its ramifications...
  10. ncbi request reprint Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT study
    Lakshmi N P Voruganti
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, and Humber River Regional Hospital, Toronto, Ontario, Canada
    Schizophr Res 88:179-86. 2006
    ....
  11. ncbi request reprint Going beyond: an adventure- and recreation-based group intervention promotes well-being and weight loss in schizophrenia
    Lakshmi N P Voruganti
    St Joseph s Healthcare, Hamilton, Ontario
    Can J Psychiatry 51:575-80. 2006
    ..To undertake a preliminary study to assess the feasibility of clinical implementation and evaluate the effectiveness of a novel adventure- and recreation-based group intervention in the rehabilitation of individuals with schizophrenia...
  12. ncbi request reprint The burden of schizophrenia on caregivers: a review
    A George Awad
    Department of Psychiatry and the Institute of Medical Science, University of Toronto, Humber River Regional Hospital, Toronto, Ontario, M6M 3Z4, Canada
    Pharmacoeconomics 26:149-62. 2008
    ....